Generic Name: Ranolazine
It is important to know, 25-30% of patients with coronary artery disease have persistent angina pectoris despite of PCI with or without optimal medical therapy
Pharmaceutical Class: Anti-anginal
Dosage Form and Strength: 500 mg extended-release tablet
Product Description:
Ranolazine acts by inhibiting the cardiac late sodium current (INa) and hence prevents sodium dependent calcium accumulation in the cell.
Additional Information
Related Products
Product Images
